10-12 September 2025, Tianjin Hlinte Bio-Tech Co., Ltd., led by founder Dr. Chen Qingzhong, showcased its core strengths at VIV Asia International Intensive Livestock Exhibition in Nanjing.
The booth attracted a flood of global professionals, with Hlinte presenting its flagship products: live vaccine against chicken coccidiosis, duck viral hepatitis type 1+3 yolk antibody, refined gosling plague virus yolk antibody, as well as Chinese medicine fermented feed, biological feed and astragalus polysaccharide powder. The team detailed the company’s innovative multivalent biotech solutions and tailored animal husbandry services, with Dr. Chen personally engaging with clients to explore cooperation, earning widespread recognition for professional expertise and premium products.
This exhibition boosted Hlinte’s domestic and international brand exposure, and forged initial cooperative ties with potential clients from Southeast Asia, Africa and beyond, laying a solid groundwork for global market

17-19 September 2025, Hlinte participated in Jakarta Livestock Exhibition, Indonesia’s largest international animal husbandry event, led by Dr. Chen Qingzhong, with core products including chicken coccidiosis live vaccine and yolk antibody, to tap into the high-potential Southeast Asian market.
Aligned with local breeding characteristics, the Hlinte team highlighted its cost-effective biopreparations, and customized disease prevention, control and breeding efficiency solutions for Southeast Asian clients, drawing high attention from local and regional buyers.
In-depth discussions with enterprises across Indonesia and neighboring countries yielded initial cooperation intentions, with the team gaining valuable insights into regional market demands to support product localization.Hlinte will further strengthen industrial collaboration in Southeast Asia, empowering the region’s high-quality development of animal husbandry.

8-10 October 2025, Dr. Chen Qingzhong led Hlinte’s team to Vietstock Vietnam International Poultry & Livestock Industry Exhibition, achieving remarkable results in this key overseas market.
The popular Hlinte booth featured star products: refined gosling plague virus yolk antibody and chicken coccidiosis live vaccine. The team elaborated on the products’ R&D strengths, application effects and after-sales support, and provided customized disease control and breeding efficiency solutions tailored to Vietnam’s poultry and livestock industry needs, winning full recognition from on-site clients.
Precise market docking led to multiple intended cooperation deals with local breeding enterprises and distributors, further expanding Hlinte’s channel layout in Vietnam. The company will continue to increase R&D and market investment in Vietnam, deepen partnerships with local industry players for mutual benefit, and drive the quality and efficiency upgrade of Vietnam’s poultry and livestock industry

16-18 October 2025, Helaiente joined AGREN Egypt International Poultry & Livestock Industry Exhibition, the most influential event in the Middle East and North Africa (MENA), led by Dr. Chen Qingzhong, marking a pivotal step into the MENA market.
As a standout exhibitor, Helaiente displayed its independently developed multivalent biopreparations, and introduced targeted disease prevention, control and breeding efficiency solutions matching MENA’s animal husbandry needs, offering professional technical consultation to global buyers. Dr. Chen also held in-depth exchanges with MENA’s industry experts and purchasers to explore industrial trends and cooperation models.
A key highlight: Dr. Chen and the team were invited to visit Egypt’s Multi Medica for Veterinary Products, with both parties reaching and signing a formal cooperation agreement on chicken coccidiosis vaccine. The exhibition elevated Hlinte’s brand awareness and influence in the MENA region, and connected the company with mult